Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population

Kidney International

Volumn 90, Issue 2, 2016, Pages 404-410

  Eriksen, Bjørn O ^a,b   Stefansson, Vidar T N ^a   Jenssen, Trond G ^a,c   Mathisen, Ulla D ^a,b   Schei, Jørgen ^a   Solbu, Marit D ^a,b   Wilsgaard, Tom ^a   Melsom, Toralf ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

cardiovascular disease; chronic kidney disease; hyperfiltration; obesity

Indexed keywords

CYSTATIN C; IOHEXOL;

ADULT; ALBUMINURIA; ARTICLE; BODY SURFACE; BODY WEIGHT; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; LONGITUDINAL STUDY; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN; WEIGHT REDUCTION; BLOOD PRESSURE; COMPLICATION; FEMALE; FOLLOW UP; MALE; METABOLISM; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; URINARY EXCRETION;

BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; IOHEXOL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RENAL ELIMINATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84992482378     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.03.021     Document Type: Article

References (46)

1. 1 Klag, M.J., Whelton, P.K., Randall, B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 (1996), 13–18.
2. 2 Hsu, C.Y., McCulloch, C.E., Darbinian, J., et al. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165 (2005), 923–928.
3. 3 Haroun, M.K., Jaar, B.G., Hoffman, S.C., et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County. Maryland. J Am Soc Nephrol 14 (2003), 2934–2941.
4. 4 Munkhaugen, J., Lydersen, S., Wideroe, T.E., et al. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am J Kidney Dis 54 (2009), 638–646.
5. 5 United States Renal Data System. 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States, 2014, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
6. 6 Hsu, C.Y., Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens 15 (2001), 99–106.
7. 7 Daien, V., Duny, Y., Ribstein, J., et al. Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis. Am J Hypertens 25 (2012), 126–132.
8. 8 SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
9. 9 Hsu, C.Y., Does non-malignant hypertension cause renal insufficiency? Evidence-based perspective. Curr Opin Nephrol Hypertens 11 (2002), 267–272.
10. 10 Freedman, B.I., Iskandar, S.S., Appel, R.G., The link between hypertension and nephrosclerosis. Am J Kidney Dis 25 (1995), 207–221.
11. 11 Kronborg, J., Solbu, M., Njølstad, I., et al. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromsø study. Nephrol Dial Transplant 23 (2008), 2818–2826.
12. 12 Halbesma, N., Jansen, D.F., Stolk, R.P., et al. Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study. Nephrol Dial Transplant 25 (2010), 1846–1853.
13. 13 Rifkin, D.E., Katz, R., Chonchol, M., et al. Blood pressure components and decline in kidney function in community-living older adults: the Cardiovascular Health Study. Am J Hypertens 26 (2013), 1037–1044.
14. 14 Hirayama, A., Konta, T., Kamei, K., et al. Blood pressure, proteinuria, and renal function decline: associations in a large community-based population. Am J Hypertens 28 (2015), 1150–1156.
15. 15 Wang, Q., Xie, D., Xu, X., et al. Blood pressure and renal function decline: a 7-year prospective cohort study in middle-aged rural Chinese men and women. J Hypertens 33 (2015), 136–143.
16. 16 Peralta, C.A., Jacobs, D.R. Jr., Katz, R., et al. Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 59 (2012), 41–49.
17. 17 Lindeman, R.D., Tobin, J.D., Shock, N.W., Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26 (1984), 861–868.
18. 18 Palatini, P., Dorigatti, F., Saladini, F., et al. Factors associated with glomerular hyperfiltration in the early stage of hypertension. Am J Hypertens 25 (2012), 1011–1016.
19. 19 Harrap, S.B., Cumming, A.D., Davies, D.L., et al. Glomerular hyperfiltration, high renin, and low- extracellular volume in high blood pressure. Hypertension 35 (2000), 952–957.
20. 20 Kotchen, T.A., Piering, A.W., Cowley, A.W., et al. Glomerular hyperfiltration in hypertensive African Americans. Hypertension 35 (2000), 822–826.
21. 21 Mimran, A., Ribstein, J., DuCailar, G., et al. Hyperfiltration in lean essential hypertension. Contrib Nephrol 119 (1996), 98–102.
22. 22 Okada, R., Yasuda, Y., Tsushita, K., et al. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant 27 (2012), 1821–1825.
23. 23 Schmieder, R.E., Veelken, R., Gatzka, C.D., et al. Predictors for hypertensive nephropathy—results of a 6-year follow-up-study in essential-hypertension. J Hypertens 13 (1995), 357–365.
24. 24 Inker, L.A., Schmid, C.H., Tighiouart, H., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367 (2012), 20–29.
25. 25 Rule, A.D., Bailey, K.R., Lieske, J.C., et al. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 83 (2013), 1169–1176.
26. 26 Mathisen, U.D., Melsom, T., Ingebretsen, O.C., et al. Estimated GFR is associated with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol 22 (2011), 927–937.
27. 27 Knight, E.L., Verhave, J.C., Spiegelman, D., et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65 (2004), 1416–1421.
28. 28 Soveri, I., Berg, U.B., Björk, J., et al. Measuring GFR: a systematic review. Am J Kidney Dis 64 (2014), 411–424.
29. 29 Eriksen, B.O., Mathisen, U.D., Melsom, T., et al. Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 78 (2010), 1305–1311.
30. 30 Perneger, T.V., Nieto, F.J., Whelton, P.K., et al. A prospective study of blood pressure and serum creatinine. Results from the ‘Clue’ Study and the ARIC Study. JAMA 269 (1993), 488–493.
31. 31 Schaeffner, E.S., Kurth, T., Bowman, T.S., et al. Blood pressure measures and risk of chronic kidney disease in men. Nephrol Dial Transplant 23 (2008), 1246–1251.
32. 32 Fox, C.S., Larson, M.G., Leip, E.P., et al. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004), 844–850.
33. 33 Kanno, A., Kikuya, M., Asayama, K., et al. Night-time blood pressure is associated with the development of chronic kidney disease in a general population: the Ohasama Study. J Hypertens 31 (2013), 2410–2417.
34. 34 Yamagata, K., Ishida, K., Sairenchi, T., et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 71 (2007), 159–166.
35. 35 Obermayr, R.P., Temml, C., Knechtelsdorfer, M., et al. Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 23 (2008), 1265–1273.
36. 36 Boucquemont, J., Heinze, G., Jager, K., et al. Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art. BMC Nephrology, 15, 2014, 45.
37. 37 Stevens, L.A., Levey, A.S., Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 20 (2009), 2305–2313.
38. 38 Singer, J.D., Willett, J.B., Applied Longitudinal Data Analysis. Modelling Change and Event Occurrence. 2003, Oxford University Press Inc., Oxford, UK.
39. 39 Rydstrom, M., Tengstrom, B., Cederquist, I., et al. Measurement of glomerular filtration rate by single-injection, single-sample techniques, using 51Cr-EDTA or iohexol. Scand J Urol Nephrol 29 (1995), 135–139.
40. 40 Brändström, E., Grzegorczyk, A., Jacobsson, L., et al. GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant 13 (1998), 1176–1182.
41. 41 Eriksson, C.G., Kallner, A., Glomerular filtration rate: a comparison between Cr-EDTA clearance and a single sample technique with a non-ionic contrast agent. Clin Biochem 24 (1991), 261–264.
42. 42 Mathisen, U.D., Melsom, T., Ingebretsen, O.C., et al. Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population. J Hypertens 30 (2012), 497–504.
43. 43 Solbu, M.D., Kronborg, J., Eriksen, B.O., et al. Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study. Atherosclerosis 201 (2008), 398–406.
44. 44 Eriksen, B.O., Løchen, M.L., Arntzen, K.A., et al. Estimated and measured GFR associate differently with retinal vasculopathy in the general population. Nephron, 2015, 175–184.
45. 45 Leffondre, K., Boucquemont, J., Tripepi, G., et al. Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches. Nephrol Dial Transplant 30 (2014), 1237–1243.
46. 46 Royston, P., Sauerbrei, W., Multivariable Model-Building. 2008, John Wiley & Sons Ltd., Chichester, UK.